Skip to content

Metabolic science since 2018

We develop and license
bioidentical ketone technology
for the brain and body.

VitaNav holds the composition, flavor, and production patents behind a non-salt, non-esterified D-BHB platform made from renewable plant sugars. Kenetik is the first product built on it. It will not be the last.

Granted US patents
4
Composition and flavor, issued 2021 through 2025.
Term through
2041
Earliest anticipated expiry March 2041.
Applications pending
3
Three in the US, plus European and Canadian filings.
Production route
Fermentation
Renewable plant sugars, carbon negative process.

The technology

A ketone the body already knows how to use.

D-BHB is the ketone the human body produces on its own during fasting, sleep, and sustained exertion. It is a preferred fuel for the brain. The obstacle has never been the molecule. It has been making the molecule taste acceptable, dose meaningfully, and cost little enough to put in something people drink every day.

VitaNav's composition pairs D-BHB in its free acid form with R-1,3-butanediol in equal parts. These are the same two moieties that make up the ketone monoester used in most published human research, (R)-3-hydroxybutyl (R)-3-hydroxybutyrate, but they are not joined by an ester bond. In the monoester that bond hydrolyzes on ingestion anyway, releasing the same two molecules to be metabolized individually. The practical consequence is metabolic equivalence: the D-BHB fraction raises blood ketones quickly, the butanediol fraction converts in the liver and extends the tail, and the published monoester literature applies to the composition directly rather than by analogy.

It is a non-salt form, so there is no added sodium or potassium load and no L-BHB isoform of the kind found in ketone salts.

  • CompositionEqual parts D-BHB (free acid) and R-1,3-butanediol, unesterified
  • FormNon-salt. No added sodium or potassium. No L-BHB isoform.
  • FeedstockRenewable plant sugars
  • ProcessProprietary carbon negative bio-fermentation
  • AdvantageImproved palatability and materially lower cost per gram than esterified ketone products
  • Supply formsConsumer-grade beverage and concentrated material for clinical and research use

That last line is the commercial point. Ketones have been studied seriously for a decade, but cost and taste confined them to elite sport and clinical trials. Producing D-BHB by fermentation from plant sugars, rather than through ester synthesis, is what moves the category into everyday formats and makes licensing worth a partner's time.

Applications

One platform, three routes to market.

VitaNav owns the intellectual property and the production route. Commercialization runs through a wholly owned consumer brand, a clinical programme, and licensing to partners building in categories we do not intend to enter ourselves.

Consumer

Kenetik

Launched by VitaNav in September 2021 and now the forward facing brand: a caffeine-free brain and body performance drink in ready to drink cans and shots, sold direct to consumer, through retail, and on Amazon. Informed Sport Certified.

drinkkenetik.com

Clinical

KenetikPro concentrate

Concentrated D-BHB material for protocols that require higher daily doses than a consumer format can deliver. Used in investigator-led work on cognitive performance, metabolic health, and neurological recovery.

research@vitanav.net

Licensing

Partner formulations

The composition and production patents are available to license for categories outside our own: food, clinical nutrition, sports nutrition, animal health, and pharmaceutical adjacents. Bulk supply agreements available alongside licensing.

partnerships@vitanav.net

Intellectual property

Patent portfolio.

Four granted US patents across three families: the composition itself, the method that makes it palatable at dose, and the fermentation route used to produce it. Earliest anticipated expiry is March 2041. Every record below links to its published filing.

Show
Inventors: Devon Price and Peter Bayne. The production family adds Roberto Vianna Nonato and is co-owned with PHB Industrial S.A. Records verified against USPTO, EPO, and WIPO publication data.
Number Title Family Filed Issued / published Status
US 12,439,945 Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent Flavor 13 May 2024 14 Oct 2025expires 4 Mar 2041 Granted
US 11,985,999 Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent Flavor 11 Oct 2021 21 May 2024expires 5 Sep 2041 Granted
US 11,141,392 Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent Flavor 4 Mar 2021 12 Oct 2021expires 4 Mar 2041 Granted
US 11,044,932 Composition of (D)-β-hydroxybutyric acid, (D)-β-hydroxyvaleric acid, and (D)-1,3 butanediol Composition 4 Mar 2021 29 Jun 2021expires 4 Mar 2041 Granted
US 2026/0047591 Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent Flavor 29 Sep 2025 19 Feb 2026 Pending
US 2024/0368644 Methods to produce therapeutic formulations comprising hydroxybutyrate and hydroxyvalerate, therapeutic formulations, and uses thereof Production 23 Jun 2022 7 Nov 2024co-owned with PHB Industrial S.A. Pending
US 2023/0079812 Composition of (D)-β-hydroxybutyric acid, (D)-1,3 butanediol, and digestible carbohydrate Composition 27 Oct 2022 16 Mar 2023 Pending
EP 4 363 599 Methods to produce therapeutic formulations comprising hydroxybutyrate and hydroxyvalerate Production 23 Jun 2022 8 May 2024co-owned with PHB Industrial S.A. Pending
CA 3,223,325 Methods to produce therapeutic formulations comprising hydroxybutyrate and hydroxyvalerate Production 23 Jun 2022 5 Jan 2023co-owned with PHB Industrial S.A. Pending
BR 11 2023 024355 Process for producing optically active mixtures of (R)-3-hydroxybutyrate and (R)-3-hydroxyvalerate Production 23 Jun 2022 6 Feb 2024co-owned with PHB Industrial S.A. National phase
WO 2023/278240 Methods to produce therapeutic formulations comprising hydroxybutyrate and hydroxyvalerate Production 23 Jun 2022 5 Jan 2023national phase entered PCT, superseded
US 2024/0292876 Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent Flavor 13 May 2024 5 Sep 2024 Issued as 12,439,945
US 2022/0095664 Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent Flavor 11 Oct 2021 31 Mar 2022 Issued as 11,985,999
US 2021/0275474 Method of improving flavor of a composition of (D)-β-hydroxybutyric acid and (D)-1,3 butanediol, and use as a nutritional supplement and therapeutic agent Flavor 4 Mar 2021 9 Sep 2021 Issued as 11,141,392
US 2021/0322349 Composition of (D)-β-hydroxybutyric acid, (D)-β-hydroxyvaleric acid, and (D)-1,3 butanediol Composition 28 Jun 2021 21 Oct 2021continued as 2023/0079812 Abandoned

The composition and flavor families are US filings. The production family, co-owned with PHB Industrial S.A., is also pending in Europe and Canada and has entered national phase in Brazil. Pre-grant publications and one abandoned continuation-in-part are shown for completeness and cross referenced to the records that superseded them, so the four granted patents are not double counted anywhere in this table.

Research

Evidence, not enthusiasm.

VitaNav supplies both consumer-grade product and concentrated material to investigator-led studies. We do not run the trials ourselves, and we do not choose the endpoints. That independence is the point.

Active and completed work spans cognitive performance and processing speed, cerebral blood flow and brain energy metabolism, sleep and recovery following physical stress, metabolic health, and neurological recovery. Pharmacokinetic characterisation of the composition has been conducted in an academic crossover design against comparator products.

We provide material, technical specifications, and certificates of analysis at no cost to qualified investigators. We ask only that results be published wherever they land.

  • Available to researchersConsumer-grade product, concentrated D-BHB material, technical specifications, certificates of analysis
  • Study areasCognitive performance, cerebral metabolism, recovery and sleep, metabolic health, neurological recovery
  • Requestsresearch@vitanav.net

Contact

Three doors, depending on why you are here.

Licensing and supply

Composition and production licensing, bulk material supply, co-development, and partnership enquiries.

partnerships@vitanav.net

Research and clinical

Study collaboration, sample requests, technical specifications, and certificates of analysis.

research@vitanav.net

Consumer and wholesale

Kenetik product questions, wholesale accounts, and bulk purchase requests.

hello@drinkkenetik.com